Schubert, M., Schmitt, A., Sellner, L., Neuber, B., Kunz, J., Wuchter, P., . . . Schmitt, M. (2019). Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: A unicentre phase I/II clinical trial protocol. BMJ Open.
Citação norma ChicagoSchubert, Maria-Luisa, et al. "Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Lymphocytes Transduced By RV-SFG.CD19.CD28.4-1BBzeta Retroviral Vector: A Unicentre Phase I/II Clinical Trial Protocol." BMJ Open 2019.
Citação norma MLASchubert, Maria-Luisa, et al. "Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Lymphocytes Transduced By RV-SFG.CD19.CD28.4-1BBzeta Retroviral Vector: A Unicentre Phase I/II Clinical Trial Protocol." BMJ Open 2019.